v3.26.3
Accrued Expenses and Other Current Liabilities (Tables)
12 Months Ended
Sep. 30, 2026
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following as of September 30, 2026 and 2025:

 

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

 

(in thousands)

 

Accrued payroll and related expenses

 

$

7,373

 

 

$

6,469

 

Accrued research and development expenses

 

 

4,412

 

 

 

1,800

 

Accrued pharmaceutical drug manufacturing

 

 

1,722

 

 

 

2,691

 

Accrued professional fees

 

 

950

 

 

 

1,386

 

Accrued other

 

 

228

 

 

 

405

 

 

 

$

14,685

 

 

$

12,751